Chemomab Therapeutics (CMMB) Tax Rate (2017 - 2023)

Chemomab Therapeutics' (CMMB) quarterly Tax Rate came in at 1.33% in Q3 2023, down 410.39% on a QoQ basis from 0.43% in Q2 2023.

Chemomab Therapeutics (CMMB) Tax Rate (2017 - 2023) Analysis & Trends

Chemomab Therapeutics (CMMB) has 5 years of Tax Rate data on file, last reported at 1.33% in Q3 2023.

Quarterly Tax Rate changed N/A year-over-year to 1.33% in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 0.03% (up 1167.0% YoY) and the FY2022 annual result came in at 1.89%, changed N/A from the prior year.
Tax Rate slipped to 1.33% in Q3 2023, from 0.43% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 8.32% in Q2 2019 to a low of 8.08% in Q2 2022.
A 3-year average of 0.49% and a median of 0.24% in 2023 frame the typical range for Tax Rate.
Annual changes were most pronounced in 2019 — Tax Rate tumbled 1183 bps — and 2023, when it jumped 851 bps.
Tracing CMMB's Tax Rate over 3 years: stood at 2.13% in 2019, then jumped by 106 bps to 0.12% in 2022, then plunged by 1199 bps to 1.33% in 2023.
The last three Tax Rate figures came in at 1.33% (Q3 2023), 0.43% (Q2 2023), and 0.24% (Q1 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.90 Bn	132.05 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	86.70 Bn	78.71 Bn	3.93 Bn	15.11%
3	Argenx Se	65.73 Bn	60.55 Bn	1.37 Bn	10.91%
4	Moderna	58.33 Bn	53.19 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	42.16 Bn	37.07 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.72 Bn	28.42 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.27 Bn	9.88 Bn	668.28 Mn	34.12%
8	Insmed	27.61 Bn	26.45 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.25 Bn	26.41 Bn	-	-
10	Chemomab Therapeutics	13.27 Mn	2.90 Mn	-	-

Download Data